Schedule 13G ownership disclosure
QUINCE THERAPEUTICS INC
Security class unavailable · CUSIP: 22053A107
Event date: 2019-05-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-151456
- Form type
- SC 13G
- Filer
- Quince Therapeutics, Inc.
- CIK
- CIK 1662774
- Filed
- May 20, 2019
- Reporting period
- May 08, 2019
- Description
- Schedule 13G beneficial ownership